Green tea and bone metabolism

National Institutes of Health, 2000, Osteoporosis prevention, diagnosis, and therapy, NIH Consensus Statement Online, 17, 1 Looker, 1995, Prevalence of low femoral bone density in older U.S. women from NHANES III, J Bone Miner Res, 10, 796, 10.1002/jbmr.5650100517 National Osteoporosis Foundation, 2002, 1 Boonen, 2008, Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective, Best Pract Res Clin Endocrinol Metab, 22, 765, 10.1016/j.beem.2008.07.002 Osteoporosis in Men. http://www.nof.org/men/index.htm (searched on April 9, 2009). U.S.D.H.H.S, 2004, The frequency of bone disease, 69 Holroyd, 2008, Epidemiology of osteoporosis, Best Pract Res Clin Endocrinol Metab, 22, 671, 10.1016/j.beem.2008.06.001 Boonen, 2008, Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I, Curr Med Res Opin, 24, 1781, 10.1185/03007990802115796 America's bone health: the state of osteoporosis and low bone mass. Available at: http://www.nof.org/advocacy/prevalence/index.htm. (accessed July 10, 2009). Konnopka, 2008, The health and economic consequences of osteopeni- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050, Osteoporosis Int, 20, 1117, 10.1007/s00198-008-0781-1 Burge, 2007, Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025, J Bone Miner Res, 22, 465, 10.1359/jbmr.061113 Ray, 1997, Medical expenditure for the treatment of osteoporotic fractures in the United States in 1995 report from the National Osteoporosis Foundation, J Bone Miner Res, 12, 24, 10.1359/jbmr.1997.12.1.24 Miller, 2003, Relative contributions of bone density, bone turnover, and clinical risk factors to long-tern fracture prediction, J Bone Miner Res, 18, 312, 10.1359/jbmr.2003.18.2.312 Hui, 1988, Age and bone mass predictors of fracture in a prospective study, J Clin Invest, 81, 1804, 10.1172/JCI113523 Marshall, 1996, Meta-analysis of how well measurements of bone mineral density predict the occurrence of osteoporotic fractures, BMJ, 312, 1254, 10.1136/bmj.312.7041.1254 Bauer, 1997, Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women, Arch Int Med, 157, 629, 10.1001/archinte.157.6.629 Cummings, 1990, Appendicular bone density and age predict hip fracture in women, JAMA, 263, 665, 10.1001/jama.263.5.665 Hamdi Kara, 2007, Habitual tea drinking and bone mineral density in postmenopausal Turkish women: Investigation of Prevalence of Postmenopausal Osteoporosis in Turkey (IPPOT Study), Int J Vitam Nutr Res, 77, 389, 10.1024/0300-9831.77.6.389 Muraki, 2007, Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic, J Orthop Sci, 12, 317, 10.1007/s00776-007-1143-0 Hegarty, 2000, Tea drinking and bone mineral density in older women, Am J Clin Nutr, 71, 1003, 10.1093/ajcn/71.4.1003 Wu, 2002, Epidemiological evidence of increased bone mineral density in habitual tea drinkers, Arch Intern Med, 162, 1001, 10.1001/archinte.162.9.1001 Hoover, 1996, Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity, Can J Physiol Pharmacol, 74, 911, 10.1139/y96-093 Devine, 2007, Tea drinking is associated with benefits on bone density in older women, Am J Clin Nutr, 86, 1243, 10.1093/ajcn/86.4.1243 Johnell, 1995, Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study, J Bone Miner Res, 10, 1802, 10.1002/jbmr.5650101125 Kanis, 1999, Risk factors for hip fracture in men from southern Europe: the MEDOS Study. Mediterranean Osteoporosis Study, Osteoporos Int, 9, 45, 10.1007/s001980050115 Shen, 2008, Protective effect of green tea polyphenols on bone loss in middle-aged female rats, Osteoporosis Int, 19, 979, 10.1007/s00198-007-0527-5 Shen, 2008, Effect of green tea polyphenols on chronic inflammation-induced bone loss in female rats, FASEB J, 314.3, 22 Nijweide, 1986, Cells of bone: proliferation, differentiation, and hormonal regulation, Physiol Rev, 66, 855, 10.1152/physrev.1986.66.4.855 Ando, 2008, RANKL/RANK/OPG: key therapeutic target in bone oncology, Curr Drug Discov Technol, 5, 263, 10.2174/157016308785739857 Matsuo, 2008, Osteoclast-osteoblast communication, Arch Biochem Biophys, 473, 201, 10.1016/j.abb.2008.03.027 Suda, 1992, Modulation of osteoclast differentiation, Endocr Rev, 13, 66, 10.1210/edrv-13-1-66 Steinbeck, 1994, NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone, J Cell Biol, 126, 765, 10.1083/jcb.126.3.765 Darden, 1996, Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase, J Bone Miner Res, 11, 671, 10.1002/jbmr.5650110515 Yavropoulou, 2008, Osteoclastogenesis—current knowledge and future perspectives, J Musculoskelet Neuronal Interact, 8, 204 Fazzalari, 2008, Bone remodeling: a review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip, Semin Cell Dev Biol, 19, 467, 10.1016/j.semcdb.2008.08.003 Banfi, 2008, Oxidative stress, free radicals and bone remodeling, Clin Chem Lab Med, 46, 1550, 10.1515/CCLM.2008.302 Manolagas, 2008, De-fense! De-fense! De-fense: scavenging H2O2 while making cholesterol, Endocrinology, 149, 3264, 10.1210/en.2008-0402 Mody, 2001, Oxidative stress modulates osteoblastic differentiation of vascular and bone cells, Free Radic Biol Med, 31, 509, 10.1016/S0891-5849(01)00610-4 Fatokun, 2008, Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species, Eur J Pharmacol, 587, 35, 10.1016/j.ejphar.2008.03.024 Bai, 2004, Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB, Biochem Biophys Res Commun, 314, 197, 10.1016/j.bbrc.2003.12.073 Dreher, 1998, Selenoproteins are expressed in fetal human osteoblast-like cells, Biochem Biophys Res Commun, 245, 101, 10.1006/bbrc.1998.8393 Fuller, 2000, A role for TGF-β in osteoclast differentiation and survival, J Cell Sci, 113, 2445, 10.1242/jcs.113.13.2445 Yang, 2001, A new superoxide-generating oxidase in murine osteoclasts, J Biol Chem, 276, 5452, 10.1074/jbc.M001004200 Sontakke, 2002, A duality in the roles of reactive oxygen species with respect to bone metabolism, Clin Chim Acta, 318, 145, 10.1016/S0009-8981(01)00766-5 Garrett, 1990, Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo, J Clin Invest, 85, 632, 10.1172/JCI114485 Polidori, 2001, Profiles of antioxidants in human plasma, Free Radic Biol Med, 30, 456, 10.1016/S0891-5849(00)00345-2 Maggio, 2003, Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study, J Clin Endocrinol Metab, 88, 1523, 10.1210/jc.2002-021496 Basu, 2001, Association between oxidative stress and bone mineral density, Biochem Biophys Res Commun, 288, 275, 10.1006/bbrc.2001.5747 Morton, 2001, Vitamin C supplement use and bone mineral density in postmenopausal women, J Bone Miner Res, 16, 135, 10.1359/jbmr.2001.16.1.135 Yang, 2000, Effects of tea consumption on nutrition and health, J Nutr, 130, 2409, 10.1093/jn/130.10.2409 Cooper, 2005, Medicinal benefits of green tea: part I. Review of noncancer health benefits, J Altern Complement Med, 11, 521, 10.1089/acm.2005.11.521 Ullmann, 2003, A single ascending dose study of epigallocatechin gallate in healthy volunteers, J Int Med Res, 31, 88, 10.1177/147323000303100205 Liao, 2001, Green tea: biochemical and biological basis for health benefits, Vitam Horm, 62, 1, 10.1016/S0083-6729(01)62001-6 van het Hof, 1999, Plasma and lipoprotein levels of tea catechins following repeated tea consumption, Proc Soc Exp Biol Med, 220, 203, 10.1046/j.1525-1373.1999.d01-34.x Lambert, 2003, Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice, J Nutr, 133, 4172, 10.1093/jn/133.12.4172 Neilson, 2006, Accumulation of catechins in bone and liver of mice fed gree ntea while under physical stress, FASEB J, 20, A570, 10.1096/fasebj.20.4.A570-b Schneider, 2009, Green tea: potential health benefits, Am Fam Physician, 79, 591 Siddiqui, 2004, Antioxidants of the beverage tea in promotion of human health, Antioxid Redox Signal, 6, 571, 10.1089/152308604773934323 Chen, 2003, Habitual tea consumption and risk of osteoporosis: a Prospective Study in the Women's Health Initiative Observational Cohort, Am J Epidemiol, 158, 772, 10.1093/aje/kwg214 Vestergaard, 2001, Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women, Maturitas, 40, 211, 10.1016/S0378-5122(01)00240-7 Hong, 2001, An analysis on the forearm bone mass density of rural female and the environmental risk factors, Wei Sheng Yan Jiu., 30, 227 Hernandez, 1995, Evaluation of bone density with peripheral quantitative computed tomography in health premenopausal, perimenopausal, and postmenopausal women, Afe Ageing, 24, 447, 10.1093/ageing/24.5.447 Hernández-Avila, 1993, Caffeine and other predictors of bone density among pre- and perimenopausal women, Epidemiology, 4, 128, 10.1097/00001648-199303000-00008 Kyriazopoulos, 2006, Lifestyle factors and forearm bone density in young Greek men, Clin Endocrinol (Oxf), 65, 234, 10.1111/j.1365-2265.2006.02581.x Saitoglu, 2007, Osteoporosis risk factors and association with somatotypes in males, Arch Med Res, 38, 746, 10.1016/j.arcmed.2007.03.009 Keramat, 2008, The assessment of osteoporosis risk factors in Iranian women compared with Indian women, BMC Musculoskelet Disord, 27, 28, 10.1186/1471-2474-9-28 Hallström, 2006, Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women, Osteoporos Int, 17, 1055, 10.1007/s00198-006-0109-y Hallanger Johnson, 2007, Fluoride-related bone disease associated with habitual tea consumption, Mayo Clin Proc, 82, 719, 10.4065/82.6.719 Cabrera, 2006, Beneficial effects of green tea—a review, J Am Coll Nutr, 25, 79, 10.1080/07315724.2006.10719518 Kasamatsu, 1996, A population survey on bone mineral density in a fishing village in Wakayama prefecture. (Part 1) Distribution of bone mineral density by sex and age based on a representative sample of the community, Nippon Eiseigaku Zasshi, 50, 1084, 10.1265/jjh.50.1084 Wang, 2008, Validation of green tea polyphenol biomarkers in a phase II human intervention trial, Food Chem Toxicol, 46, 232, 10.1016/j.fct.2007.08.007 Shen, 2009, Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats, Bone, 44, 684, 10.1016/j.bone.2008.11.018 Shen, 2008, Green tea polyphenols protects bone microarchitecture in female rats with chronic inflammation-induced bone loss, JBMR, 23, s458 Morinobu, 2008, (−)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice, Arthritis Rheum, 58, 2012, 10.1002/art.23594 Choi, 2003, Effects of (+)-catechin on the function of osteoblastic cells, Biol Pharm Bull, 26, 523, 10.1248/bpb.26.523 Greger, 1988, Iron, copper and zinc metabolism of rats fed various levels and types of tea, J Nutr, 118, 52, 10.1093/jn/118.1.52 Zeyuan, 1998, Effect of green tea and black tea on the metabolisms of mineral elements in old rats, Biol Trace Elem Res, 65, 75, 10.1007/BF02784115 Hamdaoui, 2005, Effect of green tea decoction on long-term iron, zinc and selenium status of rats, Ann Nutr Metab, 49, 118, 10.1159/000084745 Behl, 2003, Estrogen can protect neurons: modes of action, J Steroids Biochem Mol Biol, 83, 195, 10.1016/S0960-0760(02)00271-6 Almeida, 2007, Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids, J Biol Chem, 282, 27285, 10.1074/jbc.M702810200 Lean, 2003, A crucial role for thiol antioxidants in estrogen-deficiency bone loss, J Clin Invest, 112, 915, 10.1172/JCI200318859 Lean, 2005, Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation, Endocrinology, 146, 728, 10.1210/en.2004-1021 Kuruto-Niwa, 2000, Effects of tea catechins on the ERE-regulated estrogenic activity, J Agric Food Chem, 48, 6355, 10.1021/jf0008487 Shenouda, 2004, Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro, Nutr Cancer, 49, 200, 10.1207/s15327914nc4902_12 Goodin, 2003, Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro, Toxicol Sci, 69, 354, 10.1093/toxsci/69.2.354 Lee, 2004, Anti-inflammatory effect of bee venom on type II collagen-induced arthritis, Am J Chin Med, 32, 361, 10.1142/S0192415X04002016 Firestein, 2003, Evolving concepts of rheumatoid arthritis, Nature, 423, 356, 10.1038/nature01661 Schett, 2005, New insights in the mechanism of bone loss in arthritis, Curr Pharm Des., 11, 3039, 10.2174/1381612054865046 Pettit, 2001, TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis, Am J Pathol, 159, 1689, 10.1016/S0002-9440(10)63016-7 Redlich, 2002, Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin, Arthritis Rheum, 46, 785, 10.1002/art.10097 Kazantzis, 2004, Cadmium, osteoporosis and calcium metabolism, Biometals, 17, 493, 10.1023/B:BIOM.0000045727.76054.f3 Samman, 2001, Green tea or rosemary extract added to foods reduces nonheme-iron absorption, Am J Clin Nutr, 73, 607, 10.1093/ajcn/73.3.607 Aubin, 1998, Advances in the osteoblast lineage, Biochem Cell Biol, 76, 899, 10.1139/o99-005 Vali, 2007, Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells, J Nutr Biochem, 18, 341, 10.1016/j.jnutbio.2006.06.005 Chen, 2005, Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line, Osteoporos Int, 16, 2039, 10.1007/s00198-005-1995-0 Mount, 2006, Evidence that the canonical Wnt signalling pathway regulates deer antler regeneration, Dev Dyn, 235, 1390, 10.1002/dvdy.20742 Yamaguchi, 2001, Effect of polyphenols on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro, Biol Pharm Bull, 24, 1437, 10.1248/bpb.24.1437 Hayashi, 2008, (−)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts, Life Sci, 82, 1012, 10.1016/j.lfs.2008.02.017 Yamauchi, 2007, (−)-Epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts, Prostaglandins Leukot Essent Fatty Acids, 77, 173, 10.1016/j.plefa.2007.09.001 Tokuda, 2003, Incadronate amplifies prostaglandin F2α-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity, J Biol Chem, 278, 18930, 10.1074/jbc.M209159200 Ishida, 2007, Epigallocatechin gallate suppresses expression of receptor activator of NF-kappaB ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells, J Med Microbiol, 56, 1042, 10.1099/jmm.0.47029-0 Delaissé, 1986, Inhibition of bone resorption in culture by (+)-catechin, Biochem Pharmacol, 35, 3091, 10.1016/0006-2952(86)90391-6 Yun, 2007, (−)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells, J Periodontal Res, 42, 212, 10.1111/j.1600-0765.2006.00935.x Hafeez, 2006, Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB, Toxicol Appl Pharmacol, 216, 11, 10.1016/j.taap.2006.03.013 Lin, 2009, (−)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB, Biochem Biophys Res Commun, 379, 1033, 10.1016/j.bbrc.2009.01.007 Ahn, 2004, Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB, Biochem Biophys Res Commun, 313, 148, 10.1016/j.bbrc.2003.11.108 Nakagawa, 2002, Fenton reaction is primarily involved in a mechanism of (−)-epigallocatechin-3-gallate to induce osteoclastic cell death, Biochem Biophys Res Commun, 292, 94, 10.1006/bbrc.2002.6622 Nakagawa, 2007, Identification of two biologically crucial hydroxyl groups of (−)-epigallocatechin gallate in osteoclast culture, Biochem Pharmacol, 73, 34, 10.1016/j.bcp.2006.09.002 Yun, 2004, Inhibitory effects of green tea polyphenol (−)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts, J Periodontal Res, 39, 300, 10.1111/j.1600-0765.2004.00743.x Tokuda, 2007, (−)-Epigallocatechin gallate suppresses endothelin-1–induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation, FEBS Lett, 581, 1311, 10.1016/j.febslet.2007.02.052 Tokuda, 2008, (−)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts, Horm Metab Res, 40, 674, 10.1055/s-2008-1073164 Takai, 2008, (−)-Epigallocatechin gallate reduces platelet-derived growth factor-BB–stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK, Mediators Inflamm, 291808, 2008 Bickford, 2006, Nutraceuticals synergistically promote proliferation of human stem cells, Stem Cells Dev, 15, 118, 10.1089/scd.2006.15.118 Mizutani, 2001, Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells, J Bone Miner Res, 16, 2043, 10.1359/jbmr.2001.16.11.2043 Takami, 1999, Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage–colony-stimulating factor production, Cell Tissue Res, 298, 327, 10.1007/s004419900092 Felix, 1990, Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse, Endocrinology, 127, 2592, 10.1210/endo-127-5-2592 Yoshida, 1990, The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene, Nature, 345, 442, 10.1038/345442a0 Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci U S A, 95, 3597, 10.1073/pnas.95.7.3597 Baron, 1989, Molecular mechanisms of bone resorption by the osteoclast, Anat Rec, 224, 317, 10.1002/ar.1092240220 Duong, 2000, Integrins and signaling in osteoclast function, Matrix Biol, 19, 97, 10.1016/S0945-053X(00)00051-2 Weisburger, 1999, Tea and health: the underlying mechanisms, Proc Soc Exp Biol Med, 220, 271, 10.1046/j.1525-1373.1999.d01-46.x Itoh, 2005, Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis, J Urol, 173, 271, 10.1097/01.ju.0000141311.51003.87 Romas, 2002, Involvement of receptor activator of NF-κB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis, Bone, 30, 340, 10.1016/S8756-3282(01)00682-2 Miyaura, 2003, An essential role of cytosolic phospholipase A2alpha in prostaglandin E2–mediated bone resorption associated with inflammation, J Exp Med, 197, 1303, 10.1084/jem.20030015 Tatakis, 1993, Interleukin-1 and bone metabolism: a review, J Peridontol, 64, 416 Johnson, 1989, Tumoros producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice, Endocrinology, 124, 1424, 10.1210/endo-124-3-1424 Wallach, 1993, Cytokines and bone metabolism, Calcif Tissue Int, 53, 293, 10.1007/BF01351830 Perez-Edo, 2002, Bone metabolism and histomorphometric changes in rheumatoid arthritis, Scand J Rheumatol, 31, 285, 10.1080/030097402760375188 Hong, 2001, Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues, Biochem Pharmacol, 62, 1175, 10.1016/S0006-2952(01)00767-5 Tipoe, 2007, Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection, Cardiovasc Hematol Disord Drug Targets, 7, 135, 10.2174/187152907780830905 Blair, 2004, Recent advances in osteoclast biology and pathological bone resorption, Histol Histopathol, 19, 189 Kwan Tat, 2004, IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology, Cytokine Growth Factor Rev, 15, 49, 10.1016/j.cytogfr.2003.10.005 Robinson, 2007, Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines, Ann N Y Acad Sci, 1116, 432, 10.1196/annals.1402.025 Moreland, 2008, Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms., Semin Arthritis Rheum Centrella, 1988, Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures, Endocrinology, 123, 1442, 10.1210/endo-123-3-1442 Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell, 89, 747, 10.1016/S0092-8674(00)80257-3 Komori, 1997, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016/S0092-8674(00)80258-5 Schroeder, 2005, Runx2: a master organizer of gene transcription in developing and maturing osteoblasts, Birth Defects Res C Embryo Today., 75, 213, 10.1002/bdrc.20043 Rawadi, 2008, Wnt signaling and potential applications in bone diseases, Curr Drug Targets, 9, 581, 10.2174/138945008784911778 Johnson, 2004, The high bone mass family—the role of Wnt/Lrp5 signaling in the regulation of bone mass, J Musculoskelet Neuronal Interact, 4, 135 Rauner, 2007, Osteoimmunology, Int Arch Allergy Immunol, 143, 31, 10.1159/000098223 Guo, 2009, Signaling cross-talk between TGF-beta/BMP and other pathways, Cell Res, 19, 71, 10.1038/cr.2008.302 Church, 2002, Wnt regulation of chondrocyte differentiation, J Cell Sci, 115, 4809, 10.1242/jcs.00152 Shakoori, 1992, Expression of heat shock genes during differentiation of mammalian osteoblasts and promyelocytic leukemia cells, J Cell Biochem, 48, 277, 10.1002/jcb.240480308 Janssens, 2005, Transforming growth factor-beta1 to the bone, Endocr Rev, 26, 743, 10.1210/er.2004-0001 Yamaguchi, 1989, Modulation of osteoblast function by prostaglandins, Am J Physiol, 257, F755 Koshihara, 1989, Prostaglandin D2 stimulates calcification of human osteoblastic cells, Biochem Biophys Res Commun, 159, 1206, 10.1016/0006-291X(89)92238-9 Gerber, 1999, VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation, Nat Med, 5, 623, 10.1038/9467 Hakeda, 1997, Prostaglandin F2alpha stimulates tyrosine phosphorylation and mitogen-activated protein kinase in osteoblastic MC3T3-E1 cells via protein kinase C activation, Endocrinology, 138, 1821, 10.1210/en.138.5.1821 Clarke, 2008, Normal bone anatomy and physiology, Clin J Am Soc Nephrol, 3, S131, 10.2215/CJN.04151206 Delaissé, 1985, A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture, Biochem Biophys Res Commun, 133, 483, 10.1016/0006-291X(85)90932-5 Delaissé, 1984, In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption, Biochem Biophys Res Commun, 125, 441, 10.1016/0006-291X(84)90560-6 Grütter, 2000, Caspases: key players in programmed cell death, Curr Opin Struct Biol, 10, 649, 10.1016/S0959-440X(00)00146-9 Okahashi, 1998, Caspases (interleukin-1beta-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts, Bone, 23, 33, 10.1016/S8756-3282(98)00069-6 Lavrik, 2005, Caspases: pharmacological manipulation of cell death, J Clin Invest, 115, 2665, 10.1172/JCI26252 Islam, 2000, Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells, Biochem Biophys Res Commun, 270, 793, 10.1006/bbrc.2000.2536 Arlt, 2003, Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death, Oncogene, 22, 3243, 10.1038/sj.onc.1206390 Haefner, 2002, NF-kappa B: arresting a major culprit in cancer, Drug Discov Today, 7, 653, 10.1016/S1359-6446(02)02309-7 Gupta, 2004, Essential role of caspases in epigallocatechin-3-gallate–mediated inhibition of nuclear factor kappa B and induction of apoptosis, Oncogene, 23, 2507, 10.1038/sj.onc.1207353 Heath, 1984, Mouse osteoblasts synthesize collagenase in response to bone resorbing agents, Biochim Biophys Acta, 802, 151, 10.1016/0304-4165(84)90046-1 Kusano, 1998, Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption, Endocrinology, 139, 1338, 10.1210/en.139.3.1338 Blair, 2005, Osteoclast signalling pathways, Biochem Biophys Res Commun, 328, 728, 10.1016/j.bbrc.2004.11.077 Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr Rev, 20, 345, 10.1210/er.20.3.345 Pixley, 2004, CSF-1 regulation of the wandering macrophage: complexity in action, Trends Cell Biol, 14, 628, 10.1016/j.tcb.2004.09.016 Takayanagi, 2002, Signaling crosstalk between RANKL and interferons in osteoclast differentiation, Arthritis Res, 4, S227, 10.1186/ar581 Sato, 2006, Osteoclasts, rheumatoid arthritis, and osteoimmunology, Curr Opin Rheumatol, 18, 419, 10.1097/01.bor.0000231912.24740.a5 Fujita, 1984, lymphocyte subsets in osteoporosis. Effect of 1-alpha hydroxyvitamin D3, Miner Electrolyte Metab, 10, 375 Eghbali-Fatourechi, 2003, Role of RANK ligand in mediating increased bone resorption in early postmenopausal women, J Clin Invest, 111, 1221, 10.1172/JCI200317215 Wu, 2009, (−)-Epigallocatechin-3-gallate induces up-regulation of Th1 and Th2 cytokine genes in Jurkat T cells, Arch Biochem Biophys., 483, 99, 10.1016/j.abb.2008.12.010 Matsunaga, 2002, In vitro therapeutic effect of epigallocatechin gallate on nicotine-induced impairment of resistance to Legionella pneumophila infection of established MH-S alveolar macrophages, J Infect Dis, 185, 229, 10.1086/338449 Granucci, 2003, Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity, EMBO J, 22, 2546, 10.1093/emboj/cdg261 Yang, 1998, Green tea polyphenols block endotoxin-induced tumor necrosis factor—production and lethality in a murine model, J Nutr, 128, 2334, 10.1093/jn/128.12.2334 Gulati, 1993, Studies on the leaching of fluoride in tea infusions, Sci Total Environ, 138, 213, 10.1016/0048-9697(93)90416-4 Vestergaard, 2008, Effects of treatment with fluoride on bone mineral density and fracture risk—a meta-analysis, Osteoporos Int, 19, 257, 10.1007/s00198-007-0437-6 Hertog, 1993, Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study, Lancet, 342, 1007, 10.1016/0140-6736(93)92876-U Mazur, 1998, Lignan and isoflavonoid concentrations in tea and coffee, Br J Nutr, 79, 37, 10.1079/BJN19980007 Miksicek, 1993, Commonly occurring plant flavonoids have estrogenic activity, Mol Pharmacol, 44, 37 de Aloysio, 1997, Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT, Gynecol Endocrinol, 11, 289, 10.3109/09513599709152548 Whelan, 2006, Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials, Ann Pharmacother, 40, 836, 10.1345/aph.1G226 Adlercreutz, 1991, Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet, Am J Clin Nutr, 54, 1093, 10.1093/ajcn/54.6.1093 Barrett-Connor, 1994, Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study, JAMA, 271, 280, 10.1001/jama.271.4.280 Sakamoto, 2001, Effect of coffee consumption on bone metabolism, Bone, 28, 332, 10.1016/S8756-3282(00)00444-0 Lloyd, 2000, Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation, J Am Coll Nutr, 19, 256, 10.1080/07315724.2000.10718924 Debry, 1994, Coffee, source of performance or dependence?, Rev Infirm, 55